Overview

Longitudinal Study of Multi-Analyte Profile for Dyslipidemia

Status:
Unknown status
Trial end date:
2012-04-01
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to determine any changes in cardiovascular risk among individuals receiving a statin by assessing their multi-analyte profile.
Phase:
N/A
Details
Lead Sponsor:
MaiHealth Inc
Treatments:
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Pravastatin